Topic: glp-1

Over the past few years, GLP-1 medications have moved from the world of diabetes treatment into mainstream wellness culture, raising a question many people are quietly asking: are we taking them because we need them, or because we want to?

Cayman residents relying on the popular weight-loss and diabetes drug Mounjaro are bracing for higher prices after manufacturer Eli Lilly announced a 170% price hike as of September.